{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:57:22Z","timestamp":1794898642684,"version":"4.9.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573405"],"award-info":[{"award-number":["81573405"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2016YFC0800907"],"award-info":[{"award-number":["2016YFC0800907"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2017YFC131040"],"award-info":[{"award-number":["2017YFC131040"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["xx2014A014"],"award-info":[{"award-number":["xx2014A014"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.neuropharm.2022.108986","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T03:06:54Z","timestamp":1644030414000},"page":"108986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Aquaporin-4 deletion attenuates opioid-induced addictive behaviours associated with dopamine levels in nucleus accumbens"],"prefix":"10.1016","volume":"208","author":[{"given":"Yang","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-yi","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1168-2057","authenticated-orcid":false,"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuropharm.2022.108986_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.108986_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.brainresrev.2007.07.014","article-title":"Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective","volume":"56","author":"Alcaro","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2022.108986_bib3","unstructured":"Annual Report, reportAnnual Report on Drug Control in China 2020. (2020). Available from http:\/\/www.nncc626.com\/2021-07\/16\/c_1211244064.htm."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.108986_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.neuropharm.2022.108986_bib5","author":"Botz-Zapp"},{"key":"10.1016\/j.neuropharm.2022.108986_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbi.2017.08.012","article-title":"Innate immune signaling in the ventral tegmental area contributes to drug-primed reinstatement of cocaine seeking","volume":"67","author":"Brown","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.108986_bib7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1460-9568.2003.02912.x","article-title":"Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice","volume":"18","author":"Chefer","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.108986_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39945","article-title":"Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement","volume":"7","author":"Corre","year":"2018","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.108986_bib9","first-page":"1716","article-title":"AQP4knockout alleviates the lipopolysaccharideinduced inflammatory response in astrocytes via SPHK1\/MAPK\/AKT signaling","volume":"42","author":"Dai","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"14","key":"10.1016\/j.neuropharm.2022.108986_bib10","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Nat. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2022.108986_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fpsyt.2011.00064","article-title":"The dopamine hypothesis of drug addiction and its potential therapeutic value","volume":"2","author":"Diana","year":"2011","journal-title":"Front. Psychiatr."},{"issue":"8","key":"10.1016\/j.neuropharm.2022.108986_bib12","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.neurobiolaging.2007.02.015","article-title":"Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine and astrocytic modulation","volume":"29","author":"Fan","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jnr.20664","article-title":"Sex- and region-specific alterations of basal amino acid and monoamine metabolism in the brain of aquaporin-4 knockout mice","volume":"82","author":"Fan","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","article-title":"Understanding opioid reward","volume":"38","author":"Fields","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.108986_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-9081-8-20","article-title":"The gamma-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens","volume":"8","author":"Fu","year":"2012","journal-title":"Behav. Brain Funct."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1515\/revneuro-2012-0045","article-title":"Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system","volume":"23","author":"Hearing","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.108986_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","article-title":"Neural mechanisms of addiction: the role of reward-related learning and memory","volume":"29","author":"Hyman","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.108986_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2013.12.024","article-title":"Comparison of single versus repeated methamphetamine injection induced behavioral sensitization in mice","volume":"560","author":"Jing","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.108986_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s11011-019-00442-z","article-title":"Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice","volume":"34","author":"Jing","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.108986_bib20","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","article-title":"Profound neuronal plasticity in response to inactivation of the dopamine transporter","volume":"95","author":"Jones","year":"1998","journal-title":"Proc. Nat. Acad. Sci. U. S. A"},{"issue":"10","key":"10.1016\/j.neuropharm.2022.108986_bib21","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/npp.2016.32","article-title":"Diversity of dopaminergic neural circuits in response to drug exposure","volume":"41","author":"Juarez","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2022.108986_bib22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn2234","article-title":"Synaptic plasticity and addiction","volume":"8","author":"Kauer","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2007.9.2\/hkleber","article-title":"Pharmacologic treatments for opioid dependence: detoxification and maintenance options","volume":"9","author":"Kleber","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.108986_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13760-015-0520-2","article-title":"A research update on the potential roles of aquaporin 4 in neuroinflammation","volume":"116","author":"Lan","year":"2016","journal-title":"Acta Neurol. Belg."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.108986_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/npp.2012.198","article-title":"Striatal adenosine signaling regulates EAAT2 and astrocytic AQP4 expression and alcohol drinking in mice","volume":"38","author":"Lee","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2022.108986_bib26","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1093\/brain\/awz243","article-title":"Impaired D2 receptor-dependent dopaminergic transmission in prefrontal cortex of awake mouse model of Parkinson's disease","volume":"142","author":"Li","year":"2019","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.108986_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neulet.2006.05.004","article-title":"Aquaporin-4 knockout regulated cocaine-induced behavior and neurochemical changes in mice","volume":"403","author":"Li","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.108986_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2017.10.018","article-title":"Agmatine inhibits chronic morphine exposure-induced impairment of hippocampal neural progenitor proliferation in adult rats","volume":"818","author":"Liu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.108986_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41401-018-0153-0","article-title":"Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice","volume":"40","author":"Lv","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.108986_bib30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1172\/JCI231","article-title":"Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4","volume":"100","author":"Ma","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"48","key":"10.1016\/j.neuropharm.2022.108986_bib31","doi-asserted-by":"crossref","first-page":"17729","DOI":"10.1523\/JNEUROSCI.4570-11.2011","article-title":"Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons","volume":"31","author":"Matsui","year":"2011","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1523\/JNEUROSCI.17-01-00383.1997","article-title":"Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area","volume":"17","author":"Nader","year":"1997","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib33","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1152\/physrev.00011.2013","article-title":"Physiological roles of aquaporin-4 in brain","volume":"93","author":"Nagelhus","year":"2013","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib34","first-page":"313","article-title":"Predictive observation-based endpoint criteria for mice receiving total body irradiation","volume":"63","author":"Nunamaker","year":"2013","journal-title":"Comp. Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2022.108986_bib35","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1360-0443.2007.02011.x","article-title":"Self-administration of drugs in animals and humans as a model and an investigative tool","volume":"102","author":"Panlilio","year":"2007","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn3468","article-title":"Aquaporin water channels in the nervous system","volume":"14","author":"Papadopoulos","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2022.108986_bib37","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1017\/S1461145713000308","article-title":"Corticotropin-releasing factor (CRF) and alpha 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats","volume":"16","author":"Park","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.108986_bib38","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"issue":"13","key":"10.1016\/j.neuropharm.2022.108986_bib39","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/npp.2010.133","article-title":"Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications","volume":"35","author":"Peng","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.108986_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/npre.2012.7040.1","article-title":"Cocaine self-administration in the mouse: a low-cost, chronic catheter preparation","author":"Pomrenze","year":"2012","journal-title":"Nat. Prec."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J. Neurosci. Methods"},{"issue":"24","key":"10.1016\/j.neuropharm.2022.108986_bib42","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1242\/jcs.02680","article-title":"Involvement of aquaporin-4 in astroglial cell migration and glial scar formation","volume":"118","author":"Saadoun","year":"2005","journal-title":"J. Cell Sci."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.108986_bib43","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1073\/pnas.0707646105","article-title":"Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter","volume":"105","author":"Salahpour","year":"2008","journal-title":"Proc. Nat. Acad. Sci. U. S. A"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.108986_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.neulet.2008.05.103","article-title":"Heroin-induced locomotor activity and conditioned place preference in C57BL\/6J and 129P3\/J mice","volume":"440","author":"Schlussman","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/jn.1998.80.1.1","article-title":"Predictive reward signal of dopamine neurons","volume":"80","author":"Schultz","year":"1998","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13041-019-0435-6","article-title":"Determination of circuit-specific morphological adaptations in ventral tegmental area dopamine neurons by chronic morphine","volume":"12","author":"Simmons","year":"2019","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sj.npp.1300770","article-title":"Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity","volume":"31","author":"Singh","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"43","key":"10.1016\/j.neuropharm.2022.108986_bib48","doi-asserted-by":"crossref","first-page":"17675","DOI":"10.1073\/pnas.1205297109","article-title":"Increased vulnerability to cocaine in mice lacking dopamine D3 receptors","volume":"109","author":"Song","year":"2012","journal-title":"Proc. Nat. Acad. Sci. U. S. A"},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2022.108986_bib49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00427827","article-title":"Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system","volume":"79","author":"Spyraki","year":"1983","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.108986_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/neu.2008.0682","article-title":"Linking binge alcohol-induced neurodamage to brain edema and potential aquaporin-4 upregulation: evidence in rat organotypic brain slice cultures and in vivo","volume":"26","author":"Sripathirathan","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neuropharm.2022.108986_bib51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2017.09.022","article-title":"Opioid-induced rewards, locomotion, and dopamine activation: a proposed model for control by mesopontine and rostromedial tegmental neurons","volume":"83","author":"Steidl","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2022.108986_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2015.06.013","article-title":"Animal models of social contact and drug self-administration","volume":"136","author":"Strickland","year":"2015","journal-title":"Pharmacol., Biochem. Behav."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","article-title":"How addictive drugs disrupt presynaptic dopamine neurotransmission","volume":"69","author":"Sulzer","year":"2011","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2022.108986_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2011.02.011","article-title":"Dorsal as well as ventral striatal lesions affect levels of intravenous cocaine and morphine self-administration in rats","volume":"493","author":"Suto","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.108986_bib55","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archneur.64.11.1575","article-title":"Dopamine in drug abuse and addiction: results of imaging studies and treatment implications","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib56","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neuropharm.2022.108986_bib57","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/npp.2015.24","article-title":"R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats","volume":"40","author":"Wang","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.neuropharm.2022.108986_bib58","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/0024-3205(87)90695-3","article-title":"Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems","volume":"41","author":"Westerink","year":"1987","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"J. Neurosci. Rural Pract."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.108986_bib60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.108986_bib61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neulet.2008.10.065","article-title":"Aquaporin 4 deficiency modulates morphine pharmacological actions","volume":"448","author":"Wu","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cns.12012","article-title":"Aquaporin-4 deficiency attenuates opioid dependence through suppressing glutamate transporter-1 down-regulation and maintaining glutamate homeostasis","volume":"19","author":"Yan","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.108986_bib63","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.mcn.2012.02.002","article-title":"Aquaporin-4 mediates astrocyte response to beta-amyloid","volume":"49","author":"Yang","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mcn.2006.09.008","article-title":"Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes","volume":"34","author":"Zeng","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.108986_bib65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2018.08.016","article-title":"Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice","volume":"141","author":"Zhan","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.108986_bib66","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuropharm.2015.09.031","article-title":"Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice","volume":"101","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.108986_bib67","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuron.2019.01.031","article-title":"Differential Co-release of two neurotransmitters from a vesicle fusion pore in mammalian adrenal chromaffin cells","volume":"102","author":"Zhang","year":"2019","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.108986_bib68","first-page":"313","article-title":"Buprenorphine therapy for opioid use disorder","volume":"97","author":"Zoorob","year":"2018","journal-title":"Am. Fam. Physician"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:13:23Z","timestamp":1777436003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":68,"alternative-id":["S0028390822000454"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.108986","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aquaporin-4 deletion attenuates opioid-induced addictive behaviours associated with dopamine levels in nucleus accumbens","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.108986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108986"}}